JW Shinyak Launches 'Minoxfaz Tablets 2.5mg' for Precise Dose Adjustment
JW Shinyak announced on April 16 that it has launched 'Minoxfaz Tablets 2.5mg,' a low-dose minoxidil antihypertensive treatment designed to enhance medication safety for patients, and has begun full-scale marketing activities.
Minoxfaz Tablets 2.5mg is a new low-dose product that contains half the amount of minoxidil compared to the 5mg tablet. Its main indications include: ▲Hypertension due to symptomatic or target organ damage ▲Resistant hypertension that does not respond even at the maximum dose when a diuretic and two types of antihypertensive agents are used together.
A low-dose minoxidil hypertension treatment drug, 'Minopaz Tablets 2.5mg'. JW Shinyak
View original imageMinoxidil is an active ingredient that directly acts on peripheral blood vessels to lower blood pressure, and the dosage must be carefully prescribed according to the patient’s blood pressure levels and therapeutic response. In clinical settings, there has been a continuous need for low-dose treatments that allow for precise dose adjustments tailored to individual patient conditions.
Minoxfaz Tablets 2.5mg was developed in response to these needs, making more precise and safer dosing management possible. The low-dose formulation enables detailed prescriptions according to each patient's condition, helping to improve medication adherence among patients.
In particular, it is expected to become an optimized, personalized prescription option for female patients who require fine dose adjustments to minimize side effects, as well as for adult patients who are sensitive to medications.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A JW Shinyak official stated, "Minoxfaz Tablets 2.5mg was developed to provide a new treatment option for patients who require dose adjustments," adding, "We will continue to listen to feedback from frontline clinicians and further strengthen our product lineup to provide stable treatment options for both healthcare professionals and patients."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.